Keyphrases
Mutant Mice
100%
Myeloproliferative Neoplasms
100%
Receptor Inactivation
100%
Neurofibromatosis Type I
60%
Juvenile Myelomonocytic Leukemia
60%
GM-CSF Receptor
60%
Neurofibromatosis Type 1 (NF-1)
60%
Hematopoietic Stem Cells
40%
Hematopoietic Cells
40%
Stem Cells
20%
Bone Marrow
20%
Tumor Suppressor
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Myeloid Progenitors
20%
Therapeutic Benefits
20%
GTPase-activating Protein
20%
Neurofibromin
20%
Mutant Alleles
20%
Germline mutation
20%
Mx1-Cre
20%
Medicine and Dentistry
Receptor
100%
Myeloproliferative Disorder
100%
Neurofibromatosis Type I
60%
Hematopoietic Cell
60%
Granulocyte Macrophage Colony Stimulating Factor Receptor
60%
Juvenile Myelomonocytic Leukemia
60%
Stem Cell
20%
Guanosine Triphosphatase Activating Protein
20%
Granulocyte Macrophage Colony Stimulating Factor
20%
Beta Chain
20%
Germline Mutation
20%
Allele
20%
Transgene
20%
Tumor Suppressor Protein
20%
Biochemistry, Genetics and Molecular Biology
Mouse Mutant
100%
Granulocyte Macrophage Colony-Stimulating Factor Receptor
100%
Hematopoietic Cell
100%
Tumor Suppressor Protein
33%
Transgene
33%
GTPase-activating Protein
33%
Stem Cell
33%
Allele
33%
Myeloid
33%
Germline Mutation
33%
Beta Chain
33%
Granulocyte Macrophage Colony-Stimulating Factor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Mutant
100%
Receptor
100%
Myeloproliferative Disorder
100%
Neurofibromatosis Type 1
60%
Granulocyte Macrophage Colony Stimulating Factor Receptor
60%
Juvenile Myelomonocytic Leukemia
60%
Tumor Suppressor Protein
20%
Syndrome
20%
Neurofibromin
20%
Guanosine Triphosphatase Activating Protein
20%
Granulocyte Macrophage Colony Stimulating Factor
20%